81% of Retailers Planning to Encourage Customers to Shop Online Rather Than In-Store

 

We are at the finish line to prepare for Black Friday 2021, and retailers have been sweating bullets over whether aisle shelves would be stocker or not, and if the supply chain grinch would win the day. As recently as late August, according to research from Emarsys, 46% of global retail marketers considered canceling their in-store Black Friday 2021 sales due to the ongoing uncertainty around the pandemic, with 81% of retailers planning to encourage customers to shop online rather than in-store.

One thing we do know is true, though, is that the retailers that are currently winning out are treating their ecommerce and brick and mortar strategies as the same, rather than different experiences.

Abridged Thoughts:

Throughout the pandemic, there’s been an up spike in delivery and pickup in store or buy online and pick up in store. Which hopefully helps with a lot of traffic flow. So that safety and occupancy is not a concern during the holidays because I know that may be a constraint or an issue as well.

You’re going to see people that are looking to shop early because they are seeing those signs of inventory being constrained and they’re going to want to get that Christmas gift, make sure they can put it under the tree as soon as possible and not have any issues in delivery. The cutoffs are the week before Christmas, right?” – Nick Delyani, Director of Retail, Xovis

“We have seen retailers be less worried about supply chain issues and empty shelves as we approach black friday and some retailers have even increased their spend as we got closer. No one could go anywhere last year so ecommerce was sky high, we will see more brick and mortar this year but the convenience and supply issues will help the ecommerce numbers be pretty equal to last year or maybe even a little more.” – Nick Talbert, VP of Marketing, Quartile

More Stories Like This:

Holiday Demand Forces Retailers to Get Creative with Hiring Strategies

Retailers Invested in Fulfillment and Demand Forecasting Post-Pandemic. Will it Pay Off for Black Friday?

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More